The DOI matches its Crossref record; 123 of the 123 references it cites were found in a registry or an index.
Crohn Disease: Epidemiology, Diagnosis, and Management
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
Hugot, J.-P., Chamaillard, M., Zouali, H., Lesage, S., Cézard, J.-P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C. A., Gassull, M., et al. (2001) · Nature · doi:10.1038/35079107 · Cited by 5,591
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
Ogura, Y., Bonen, D. K., Inohara, N., Nicolae, D. L., Chen, F. F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R., Duerr, R. H., et al. (2001) · Nature · doi:10.1038/35079114 · Cited by 5,030
Molodecky, N. A., Soon, I. S., Rabi, D. M., Ghali, W. A., Ferris, M., Chernoff, G., Benchimol, E. I., Panaccione, R., Ghosh, S., Barkema, H. W., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.10.001 · Cited by 4,833
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
Colombel, J. F., Sandborn, W. J., Reinisch, W., Mantzaris, G. J., Kornbluth, A., Rachmilewitz, D., Lichtiger, S., D'Haens, G., Diamond, R. H., Broussard, D. L., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0904492 · Cited by 3,143
Loftus, E. V. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.01.063 · Cited by 3,117
Ford Alexander, C., Paul, M., Hanauer Steven, B., 谭蓓, & Dong, W. Z. (2001) · Cited by 3,020
Infliximab for the Treatment of Fistulas in Patients with Crohn's Disease
Present, D. H., Rutgeerts, P., Targan, S., Hanauer, S. B., Mayer, L., van Hogezand, R. A., Podolsky, D. K., Sands, B. E., Braakman, T., DeWoody, K. L., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199905063401804 · Cited by 2,752
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
Sandborn, W. J., Feagan, B. G., Rutgeerts, P., Hanauer, S., Colombel, J.-F., Sands, B. E., Lukas, M., Fedorak, R. N., Lee, S., Bressler, B., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1215739 · Cited by 2,719
Baumgart, D. C., & Sandborn, W. J. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60026-9 · Cited by 2,154
Gomollón, F., Dignass, A., Annese, V., Tilg, H., Van Assche, G., Lindsay, J. O., Peyrin-Biroulet, L., Cullen, G. J., Daperno, M., Kucharzik, T., et al. (2017) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjw168 · Cited by 2,057
Predictability of the postoperative course of Crohn's disease
Rutgeerts, P., Geboes, K., Vantrappen, G., Beyls, J., Kerremans, R., & Hiele, M. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)90613-6 · Cited by 1,820
The Microbiome in Inflammatory Bowel Disease: Current Status and the Future Ahead
Kostic, A. D., Xavier, R. J., & Gevers, D. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.02.009 · Cited by 1,789
Hanauer, S. B., Sandborn, W. J., Rutgeerts, P., Fedorak, R. N., Lukas, M., MacIntosh, D., Panaccione, R., Wolf, D., & Pollack, P. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.030 · Cited by 1,715
Management of Crohn's Disease in Adults
Lichtenstein, G. R., Hanauer, S. B., & Sandborn, W. J. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2008.168 · Cited by 1,173
The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota
Schwartz, D. A., Loftus, E. V., Tremaine, W. J., Panaccione, R., Harmsen, W. S., Zinsmeister, A. R., & Sandborn, W. J. (2002) · Gastroenterology · doi:10.1053/gast.2002.32362 · Cited by 1,144
Certolizumab Pegol for the Treatment of Crohn's Disease
Sandborn, W. J., Feagan, B. G., Stoinov, S., Honiball, P. J., Rutgeerts, P., Mason, D., Bloomfield, R., & Schreiber, S. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067594 · Cited by 1,143
Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease
Sandborn, W. J., Gasink, C., Gao, L.-L., Blank, M. A., Johanns, J., Guzzo, C., Sands, B. E., Hanauer, S. B., Targan, S., Rutgeerts, P., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1203572 · Cited by 1,134
Beaugerie, L., Brousse, N., Bouvier, A. M., Colombel, J. F., Lémann, M., Cosnes, J., Hébuterne, X., Cortot, A., Bouhnik, Y., Gendre, J. P., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61302-7 · Cited by 1,115
Danese, S., & Fiocchi, C. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1102942 · Cited by 1,102
Progressive Multifocal Leukoencephalopathy after Natalizumab Therapy for Crohn's Disease
Van Assche, G., Van Ranst, M., Sciot, R., Dubois, B., Vermeire, S., Noman, M., Verbeeck, J., Geboes, K., Robberecht, W., & Rutgeerts, P. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051586 · Cited by 1,060
Treatment of Crohn's Disease with 6-Mercaptopurine: A Long-Term, Randomized, Double-Blind Study
Present, D. H., Korelitz, B. I., Wisch, N., Glass, J. L., Sachar, D. B., & Pasternack, B. S. (1980) · New England Journal of Medicine · doi:10.1056/nejm198005013021801 · Cited by 1,042
Hou, J. K., Abraham, B., & El-Serag, H. (2011) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.44 · Cited by 1,009
Laboratory markers in IBD: useful, magic, or unnecessary toys?
Vermeire, S., Van Assche, G., & Rutgeerts, P. (2006) · Gut · doi:10.1136/gut.2005.069476 · Cited by 952
Natalizumab Induction and Maintenance Therapy for Crohn's Disease
Sandborn, W. J., Colombel, J. F., Enns, R., Feagan, B. G., Hanauer, S. B., Lawrance, I. C., Panaccione, R., Sanders, M., Schreiber, S., Targan, S., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043335 · Cited by 927
Serious Infections and Mortality in Association With Therapies for Crohn’s Disease: TREAT Registry
Lichtenstein, G. R., Feagan, B. G., Cohen, R. D., Salzberg, B. A., Diamond, R. H., Chen, D. M., Pritchard, M. L., & Sandborn, W. J. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.03.002 · Cited by 905
Frolkis, A. D., Dykeman, J., Negrón, M. E., deBruyn, J., Jette, N., Fiest, K. M., Frolkis, T., Barkema, H. W., Rioux, K. P., Panaccione, R., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.07.041 · Cited by 892
Harbord, M., Annese, V., Vavricka, S. R., Allez, M., Barreiro-de Acosta, M., Boberg, K. M., Burisch, J., De Vos, M., De Vries, A.-M., Dick, A. D., et al. (2016) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjv213 · Cited by 827
Lichtenstein, G. R., Feagan, B. G., Cohen, R. D., Salzberg, B. A., Diamond, R. H., Price, S., Langholff, W., Londhe, A., & Sandborn, W. J. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2012.218 · Cited by 791
Cleynen, I., Boucher, G., Jostins, L., Schumm, L. P., Zeissig, S., Ahmad, T., Andersen, V., Andrews, J. M., Annese, V., Brand, S., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00465-1 · Cited by 779
Smoking and Inflammatory Bowel Disease: A Meta-analysis
Mahid, S. S., Minor, K. S., Soto, R. E., Hornung, C. A., & Galandiuk, S. (2006) · Mayo Clinic Proceedings · doi:10.4065/81.11.1462 · Cited by 774
Gionchetti, P., Dignass, A., Danese, S., Magro Dias, F. J., Rogler, G., Lakatos, P. L., Adamina, M., Ardizzone, S., Buskens, C. J., Sebastian, S., et al. (2017) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjw169 · Cited by 771
Sandborn, W. J., Feagan, B. G., Fedorak, R. N., Scherl, E., Fleisher, M. R., Katz, S., Johanns, J., Blank, M., & Rutgeerts, P. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.07.014 · Cited by 753
A Comparison of Methotrexate with Placebo for the Maintenance of Remission in Crohn's Disease
Feagan, B. G., Fedorak, R. N., Irvine, E. J., Wild, G., Sutherland, L., Steinhart, A. H., Greenberg, G. R., Koval, J., Wong, C. J., Hopkins, M., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006013422202 · Cited by 727
Crohn's disease in Olmsted County, Minnesota, 1940–1993: Incidence, prevalence, and survival
Loftus, E. V., Silverstein, M. D., Sandborn, W. J., Tremaine, W. J., Harmsen, W. S., & Zinsmeister, A. R. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70421-4 · Cited by 623
Prevalence of Inflammatory Bowel Disease Among Adults Aged ≥18 Years — United States, 2015
Dahlhamer, J. M., Zammitti, E. P., Ward, B. W., Wheaton, A. G., & Croft, J. B. (2016) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6542a3 · Cited by 622
Crohn's disease management after intestinal resection: a randomised trial
De Cruz, P., Kamm, M. A., Hamilton, A. L., Ritchie, K. J., Krejany, E. O., Gorelik, A., Liew, D., Prideaux, L., Lawrance, I. C., Andrews, J. M., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61908-5 · Cited by 619
Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease
Prefontaine, E., MacDonald, J. K., & Sutherland, L. R. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000545.pub3 · Cited by 604
Geographical variability and environmental risk factors in inflammatory bowel disease
Ng, S. C., Bernstein, C. N., Vatn, M. H., Lakatos, P. L., Loftus, E. V., Tysk, C., O'Morain, C., Moum, B., Colombel, J.-F., & on behalf of the Epidemiology and Natural History Task Force of the International Organization of Inflammatory Bowel Disease (IOIBD) (2013) · Gut · doi:10.1136/gutjnl-2012-303661 · Cited by 592
Primary sclerosing cholangitis
Hirschfield, G. M., Karlsen, T. H., Lindor, K. D., & Adams, D. H. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60096-3 · Cited by 592
A Comparison of Budesonide with Prednisolone for Active Crohn's Disease
Rutgeerts, P., Lofberg, R., Malchow, H., Lamers, C., Olaison, G., Jewell, D., Danielsson, A., Goebell, H., Thomsen, O. O., Lorenz-Meyer, H., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199409293311304 · Cited by 589
Jess, T., Gamborg, M., Matzen, P., Munkholm, P., & Sorensen, T. I. A. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.00287.x · Cited by 586
Farraye, F. A., Odze, R. D., Eaden, J., & Itzkowitz, S. H. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.12.037 · Cited by 532
Risk of Melanoma and Nonmelanoma Skin Cancer Among Patients With Inflammatory Bowel Disease
Long, M. D., Martin, C. F., Pipkin, C. A., Herfarth, H. H., Sandler, R. S., & Kappelman, M. D. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.05.004 · Cited by 526
The incidence and management of infusion reactions to infliximab: a large center experience
Cheifetz, A. (2003) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(03)00231-4 · Cited by 491
Self-citationKotlyar, D. S., Osterman, M. T., Diamond, R. H., Porter, D., Blonski, W. C., Wasik, M., Sampat, S., Mendizabal, M., Lin, M. V., & Lichtenstein, G. R. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2010.09.016 · Cited by 477
ACG clinical guideline: Preventive care in inflammatory bowel disease
Farraye, F. A., Melmed, G. Y., Lichtenstein, G. R., & Kane, S. V. (2017) · American Journal of Gastroenterology · doi:10.1038/ajg.2016.537 · Cited by 473
Antibiotic Exposure and IBD Development Among Children: A Population-Based Cohort Study
Kronman, M. P., Zaoutis, T. E., Haynes, K., Feng, R., & Coffin, S. E. (2012) · Pediatrics · doi:10.1542/peds.2011-3886 · Cited by 445
Halfvarson, J., Bodin, L., Tysk, C., Lindberg, E., & Järnerot, G. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00385-8 · Cited by 426
Gradel, K. O., Nielsen, H. L., Schønheyder, H. C., Ejlertsen, T., Kristensen, B., & Nielsen, H. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.04.001 · Cited by 424
Concordance of Inflammatory Bowel Disease among Danish Twins: Results of a Nationwide Study
M. Orholm, V. B. (2000) · Scandinavian Journal of Gastroenterology · doi:10.1080/003655200451207 · Cited by 404
Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease
Chande, N., Patton, P. H., Tsoulis, D. J., Thomas, B. S., & MacDonald, J. K. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000067.pub3 · Cited by 402
Dietary Risk Factors for Inflammatory Bowel Disease: A Multicenter Case-Control Study in Japan
Sakamoto, N., Kono, S., Wakai, K., Fukuda, Y., Satomi, M., Shimoyama, T., Inaba, Y., Miyake, Y., Sasaki, S., Okamoto, K., et al. (2005) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200502000-00009 · Cited by 398
Primary Sclerosing Cholangitis
(2007) · Gastroenterology Nursing · doi:10.1097/01.sga.0000267930.44372.16 · Cited by 382
Thiopurine Methyltransferase Genotype Predicts Therapy-Limiting Severe Toxicity from Azathioprine
Black, A. J., McLeod, H. L., Capell, H. A., Powrie, R. H., Matowe, L. K., Pritchard, S. C., Collie-Duguid, E. S. R., & Reid, D. M. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-9-199811010-00007 · Cited by 374
Familial empirical risks for inflammatory bowel disease: differences between Jews and non-Jews.
Yang, H., McElree, C., Roth, M. P., Shanahan, F., Targan, S. R., & Rotter, J. I. (1993) · Gut · doi:10.1136/gut.34.4.517 · Cited by 369
The Risk of Retention of the Capsule Endoscope in Patients with Known or Suspected Crohn's Disease
Cheifetz, A. S., Kornbluth, A. A., Legnani, P., Schmelkin, I., Brown, A., Lichtiger, S., & Lewis, B. S. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00761.x · Cited by 364
Self-citationExtraintestinal manifestations and complications in IBD
Ott, C., & Schölmerich, J. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.117 · Cited by 351
American Gastroenterological Association
(1958) · The Lancet · doi:10.1016/s0140-6736(58)92067-1 · Cited by 350
Peeters, M., Joossens, S., Vermeire, S., Vlietinck, R., Bossuyt, X., & Rutgeerts, P. (2001) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.03613.x · Cited by 344
Review article: the natural history of postoperative Crohn's disease recurrence
Buisson, A., Chevaux, J. ‐., Allen, P. B., Bommelaer, G., & Peyrin‐Biroulet, L. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2012.05002.x · Cited by 344
Genetics versus environment in inflammatory bowel disease: results of a British twin study
Thompson, N. P., Driscoll, R., Pounder, R. E., & Wakefield, A. J. (1996) · BMJ · doi:10.1136/bmj.312.7023.95 · Cited by 336
Tumor Necrosis Factor Inhibitors for Inflammatory Bowel Disease
Nielsen, O. H., & Ainsworth, M. A. (2013) · New England Journal of Medicine · doi:10.1056/nejmct1209614 · Cited by 334
Beyond Gene Discovery in Inflammatory Bowel Disease: The Emerging Role of Epigenetics
Ventham, N. T., Kennedy, N. A., Nimmo, E. R., & Satsangi, J. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.05.050 · Cited by 320
Amre, D. K., D'Souza, S., Morgan, K., Seidman, G., Lambrette, P., Grimard, G., Israel, D., Mack, D., Ghadirian, P., Deslandres, C., et al. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01411.x · Cited by 319
Picco, M. F. (2010) · Yearbook of Gastroenterology · doi:10.1016/s0739-5930(09)79399-7 · Cited by 315
Papp, K. A., Gottlieb, A. B., Naldi, L., Pariser, D., Ho, V., Goyal, K., Fakharzadeh, S., Chevrier, M., Calabro, S., Langholff, W., et al. (2015) · PubMed · Cited by 312
Prantera, C., Zannoni, F., Scribano, M. L., Berto, E., Andreoli, A., Kohn, A., & Luzi, C. (1996) · PubMed · Cited by 309
Increased Risk for Non-Melanoma Skin Cancer in Patients With Inflammatory Bowel Disease
Long, M. D., Herfarth, H. H., Pipkin, C. A., Porter, C. Q., Sandler, R. S., & Kappelman, M. D. (2010) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2009.11.024 · Cited by 306
The Risk of Oral Contraceptives in the Etiology of Inflammatory Bowel Disease: A Meta-Analysis
Cornish, J. A., Tan, E., Simillis, C., Clark, S. K., Teare, J., & Tekkis, P. P. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.02064.x · Cited by 297
Dassopoulos, T., Sultan, S., Falck–Ytter, Y. T., Inadomi, J. M., & Hanauer, S. B. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.10.046 · Cited by 297
Hospitalisations and surgery in Crohn's disease
Bernstein, C. N., Loftus, E. V., Ng, S. C., Lakatos, P. L., & Moum, B. (2012) · Gut · doi:10.1136/gutjnl-2011-301397 · Cited by 294
Ankylosing spondylitis and bowel disease
Rudwaleit, M., & Baeten, D. (2006) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2006.03.010 · Cited by 275
Methotrexate for induction of remission in refractory Crohn's disease
McDonald, J. W., Wang, Y., Tsoulis, D. J., MacDonald, J. K., & Feagan, B. G. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003459.pub4 · Cited by 270
Cosnes, J., Bourrier, A., Laharie, D., Nahon, S., Bouhnik, Y., Carbonnel, F., Allez, M., Dupas, J., Reimund, J., Savoye, G., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.04.048 · Cited by 268
Ananthakrishnan, A. N., Higuchi, L. M., Huang, E. S., Khalili, H., Richter, J. M., Fuchs, C. S., & Chan, A. T. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-156-5-201203060-00007 · Cited by 262
Rieder, F., Latella, G., Magro, F., Yuksel, E. S., Higgins, P. D. R., Di Sabatino, A., de Bruyn, J. R., Rimola, J., Brito, J., Bettenworth, D., et al. (2016) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjw055 · Cited by 261
Management of Crohn's disease in adults
Hanauer, S. B., Sandborn, W., & The Practice Parameters Committee of the American College of Gastroenterology (2001) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.03671.x · Cited by 261
Budesonide for induction of remission in Crohn's disease
Rezaie, A., Kuenzig, M. E., Benchimol, E. I., Griffiths, A. M., Otley, A. R., Steinhart, A. H., Kaplan, G. G., & Seow, C. H. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000296.pub4 · Cited by 260
Zholudev, A., Zurakowski, D., Young, W., Leichtner, A., & Bousvaros, A. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.40369.x · Cited by 259
Early Azathioprine Therapy Is No More Effective Than Placebo for Newly Diagnosed Crohn's Disease
Panés, J., López–SanRomán, A., Bermejo, F., García–Sánchez, V., Esteve, M., Torres, Y., Domènech, E., Piqueras, M., Gomez–García, M., Gutiérrez, A., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.06.009 · Cited by 252
A Prospective Study of Cigarette Smoking and the Risk of Inflammatory Bowel Disease in Women
Higuchi, L. M., Khalili, H., Chan, A. T., Richter, J. M., Bousvaros, A., & Fuchs, C. S. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2012.196 · Cited by 244
Corticosteroids for maintenance of remission in Crohn's disease
Steinhart, A. H., Ewe, K., Griffiths, A. M., Modigliani, R., & Thomsen, O. O. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000301 · Cited by 224
Tumor Necrosis Factor Inhibitors for Inflammatory Bowel Disease
(2013) · New England Journal of Medicine · doi:10.1056/nejmc1312800 · Cited by 214
Methotrexate for maintenance of remission in Crohn's disease
Patel, V., Wang, Y., MacDonald, J. K., McDonald, J. W., & Chande, N. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006884.pub3 · Cited by 180
A Practical Guide to Vaccinating the Inflammatory Bowel Disease Patient
Wasan, S. K., Baker, S. E., Skolnik, P. R., & Farraye, F. A. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2009.733 · Cited by 179
Velayos, F. S., Kahn, J. G., Sandborn, W. J., & Feagan, B. G. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.12.035 · Cited by 179
The limitations of corticosteroid therapy in Crohn’s disease
Rutgeerts, P. J. (2001) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2001.01060.x · Cited by 166
The Risk of Developing Crohn's Disease After an Appendectomy: A Meta-Analysis
Kaplan, G. G., Jackson, T., Sands, B. E., Frisch, M., Andersson, R. E., & Korzenik, J. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.02118.x · Cited by 164
Vaccinating the inflammatory bowel disease patient: Deficiencies in gastroenterologists knowledge
Wasan, S. K., Coukos, J. A., & Farraye, F. A. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21667 · Cited by 160
Management of Active Crohn Disease
Cheifetz, A. S. (2013) · JAMA · doi:10.1001/jama.2013.4466 · Cited by 157
Self-citationRisk factors for inflammatory bowel disease in the general population
Rodríguez, L. A. G., González‐Pérez, A., Johansson, S., & Wallander, M.-A. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02564.x · Cited by 156
Regueiro, M. D., Velayos, F. S., Greer, J. B., Bougatsos, C., Chou, R., Sultan, S., & Singh, S. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.10.039 · Cited by 147
Hormone Therapy Increases Risk of Ulcerative Colitis but not Crohn's Disease
Khalili, H., Higuchi, L. M., Ananthakrishnan, A. N., Manson, J. E., Feskanich, D., Richter, J. M., Fuchs, C. S., & Chan, A. T. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.07.096 · Cited by 142
Burgmann, T., Clara, I., Graff, L., Walker, J., Lix, L., Rawsthorne, P., McPhail, C., Rogala, L., Miller, N., & Bernstein, C. N. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.03.003 · Cited by 135
Extraintestinal manifestations of inflammatory bowel disease
Williams, H. R. T., Walker, D. G., & Orchard, T. R. (2008) · Current Gastroenterology Reports · doi:10.1007/s11894-008-0108-6 · Cited by 129
Infectious and Malignant Complications of TNF Inhibitor Therapy in IBD
Targownik, L. E., & Bernstein, C. N. (2013) · The American Journal of Gastroenterology · doi:10.1038/ajg.2013.294 · Cited by 122
Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease
Chande, N., Townsend, C., Parker, C. E., & MacDonald, J. K. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000545.pub5 · Cited by 122
The Utility of Capsule Endoscopy in Patients With Suspected Crohn's Disease
Tukey, M. H., Pleskow, D. K., Legnani, P. E., Cheifetz, A. S., & Moss, A. C. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.404 · Cited by 113
Self-citationGisbert, J. P., Gomollón, F., Maté, J., & Pajares, J. M. (2002) · Digestive Diseases and Sciences · doi:10.1023/a:1017987229718 · Cited by 112
Dulai, P. S., Siegel, C. A., Colombel, J., Sandborn, W. J., & Peyrin‐Biroulet, L. (2014) · Gut · doi:10.1136/gutjnl-2014-307126 · Cited by 112
Wasan, S. K., Calderwood, A. H., Long, M. D., Kappelman, M. D., Sandler, R. S., & Farraye, F. A. (2013) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000437737.68841.87 · Cited by 110
Setshedi, M., Epstein, D., Winter, T. A., Myer, L., Watermeyer, G., & Hift, R. (2011) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2011.06865.x · Cited by 105
Sulfasalazine and mesalazine for the maintenance therapy of Crohn's disease: a meta-analysis.
Steinhart, A. H., Hemphill, D. J., & Greenberg, G. R. (1994) · PubMed · Cited by 100
Use of the Given® Patency System for the screening of patients at high risk for capsule retention
Signorelli, C., Rondonotti, E., Villa, F., et al. (2006) · Digestive and Liver Disease · doi:10.1016/j.dld.2006.01.010 · Cited by 99
Panaccione, R., Rutgeerts, P. J., Sandborn, W. J., Feagan, B. G., Schreiber, S., & Ghosh, S. K. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03753.x · Cited by 99
A meta-analysis of broad-spectrum antibiotic therapy in patients with active Crohn's disease
Rahimi, R., Nikfar, S., Rezaie, A. R., & Abdollahi, M. R. (2006) · Clinical Therapeutics · doi:10.1016/j.clinthera.2006.12.012 · Cited by 98
Corticosteroid-associated complications in elderly Crohn's disease patients.
Akerkar, G. A., Peppercorn, M. A., Hamel, M. B., et al. (1997) · PubMed · Cited by 96
Smith, M. A., Irving, P. M., Marinaki, A. M., & Sanderson, J. D. (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2010.04330.x · Cited by 95
Surgery for luminal Crohn’s disease
Yamamoto, T., & Watanabe, T. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i1.78 · Cited by 87
Singh, S., Heien, H. C., Sangaralingham, L. R., Schilz, S. R., Kappelman, M. D., Shah, N. D., & Loftus, E. V. (2016) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2016.03.038 · Cited by 69
Serum sickness, encephalitis and other complications of anti-cytokine therapy
Vermeire, S., Assche, G. V., & Rutgeerts, P. J. (2009) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2008.12.005 · Cited by 51
Gene–environment interactions in inflammatory bowel disease pathogenesis
Wang, M., & Achkar, J. (2015) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000188 · Cited by 45
Schwartz, D. A., Ghazi, L. J., & Regueiro, M. D. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000377 · Cited by 40
Feuerstein, J. D., Castillo, N. E., Siddique, S. S., Lewandowski, J. J., Geissler, K., Martinez-Vazquez, M. A., Thukral, C., Leffler, D. A., & Cheifetz, A. S. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.09.042 · Cited by 40
Self-citationSafety Profile of Thiopurines in Crohn Disease
Qiu, Y., Mao, R., Zhang, S., Li, M.-Y., Guo, J., Chen, B., He, Y., Zeng, Z., & Chen, M. (2015) · Medicine · doi:10.1097/md.0000000000001513 · Cited by 39
Use of laboratory testing to guide 6-mercaptopurine/azathioprine therapy
Lichtenstein, G. R. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.061 · Cited by 38
Thiopurine metabolism monitoring: implications in inflammatory bowel diseases
Dewit, O., Stärkel, P., & Roblin, X. (2010) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02346.x · Cited by 33
Towards an understanding of the role of NOD2/CARD15 in the pathogenesis of Crohn's disease
Philpott, D. J., & Viala, J. (2004) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2003.12.004 · Cited by 33
Anti–Tumor Necrosis Factor-α Monotherapy Versus Combination Therapy with an Immunomodulator in IBD
Dulai, P. S., Siegel, C. A., & Peyrin‐Biroulet, L. (2014) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2014.05.009 · Cited by 20
Medical Management of Crohn's Disease
Feldman, P., Wolfson, D. L., & Barkin, J. S. (2007) · Clinics in Colon and Rectal Surgery · doi:10.1055/s-2007-991026 · Cited by 18
Immune-mediated Reactions to Anti-tumor Necrosis Factors in Inflammatory Bowel Disease
Feuerstein, J. D., Cullen, G. J., & Cheifetz, A. S. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000279 · Cited by 12
Self-citationPrimary sclerosing cholangitis: an update
Feuerstein, J. D., & Tapper, E. (2013) · Cited by 4
Self-citationMethotrexate and Risk for Lymphoma
Whitmore, S. E. (2007) · Archives of Dermatology · doi:10.1001/archderm.143.5.663-b · Cited by 3
Cited by
Roda, G., Chien Ng, S., Kotze, P. G., Argollo, M., Panaccione, R., Spinelli, A., Kaser, A., Peyrin-Biroulet, L., & Danese, S. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0156-2 · Cited by 1,023
Kaymaz, K., & Beikler, T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20143394 · Cited by 534
Feuerstein, J. D., Ho, E. Y., Shmidt, E., Singh, H., Falck-Ytter, Y., Sultan, S., Terdiman, J. P., Sultan, S., Cohen, B. L., Chachu, K., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.04.022 · Cited by 407
Self-citation
Metadata
- Authors
- Feuerstein, J. D., & Cheifetz, A. S.
- Venue
- Mayo Clinic Proceedings
- Publisher
- Elsevier BV
- Published
- 2017-07
- Volume
- 92
- Issue
- 7
- Pages
- 1088-1103
- ISSN
- 0025-6196 (ISSN-L)
- OpenAlex
- W2624076097
- Cited by
- 548
- References
- 123
- FWCI
- 16.04
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.